Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 203Generated: October 23, 2026

1-Methylpiperazine → N-[5-(4-methylpiperazin-1-yl)pyrazin-2-yl]acetamide

https://huagongshe.com/en/reaction/203

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-MethylpiperazineHCID 53167—
ReactantN-(5-Bromopyrazin-2-YL)acetamideHCID 58574049—
ReagentPotassium tert-butoxideHCID 23665647—
CatalystTris(1,1-dimethylethyl)phosphineHCID 83681—
CatalystBis(dibenzylideneacetone)palladiumHCID 9811564—
SolventDimethylformamideHCID 6228—
ProductN-[5-(4-methylpiperazin-1-yl)pyrazin-2-yl]acetamideHCID 5998394179.51%

Reaction Conditions

Temperature120 °C

Reaction Steps

1-methylpiperazine (2.318 g, 23.14 mmol), N-(5-bromopyrazin-2-yl)acetamide (1 g, 4.63 mmol), tri-tert-butylphosphine (1.873 g, 9.26 mmol), tris(dibenzylideneacetone)dipalladium (0.085 g, 0.09 mmol) and potassium 2-methylpropan-2-olate (1.039 g, 9.26 mmol) were suspended in DMF (9.26 ml) and sealed into a microwave tube. The reaction was heated to 120 °C for 40 minutes in the microwave reactor and cooled to RT. The mixture was diluted with methanol and acidified with HCl, then the solution was purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 7M NH3/MeOH and pure fractions were evaporated to dryness to afford N-(5-(4-methylpiperazin-1-yl)pyrazin-2-yl)acetamide (0.866 g, 80 %) as a dark oil. Used without further purification.

Provenance & Evidence

Source dataset750 AstraZeneca ELN dataset
ORD IDord-96727602adb24b28af9c737e24f7315c
Source note750 AstraZeneca ELN dataset